// App-Quantinova.ai

POS0340 (2021) : VASCULAR IMAGING IN PATIENTS WITH REFRACTORY TAKAYASU ARTERITIS TREATED WITH TOCILIZUMAB: ANALYSIS FROM A RANDOMIZED CONTROLLED TRIAL

Researchers

Presenter

  • Y. Nakaoka

Principal Investigators

  • M. Yanagawa

  • A. Hata

  • K. Yamashita

  • N. Okada

  • H. Hayashi

  • D. Jayne

Medical Centers

  • National Cerebral and Cardiovascular Center Research Institute, Department of Vascular Physiology, Suita, Japan

  • Hokkaido University Graduate School of Medicine, Cardiovascular Medicine, Hokkaido, Japan

  • Osaka University Graduate School of Medicine, Department of Diagnostic and Interventional Radiology, Osaka, Japan

  • Osaka University Graduate School of Medicine, Department of Diagnostic and Interventional Radiology, Osaka, Japan

  • Chugai Pharmaceutical Co., Ltd., Medical Science Department, Medical Affairs Division, Tokyo, Japan

  • Chugai Pharmaceutical Co., Ltd., Biometrics Department, Clinical Development Division, Tokyo, Japan

  • Chugai Pharmaceutical Co., Ltd., Biometrics Department, Clinical Development Division, Tokyo, Japan

  • Nippon Medical School, Department of Physiology, Tokyo, Japan

  • University of Cambridge, Department of Oncology, Cambridge, United Kingdom

Locations

  • Japan

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Takayasu arteritis

Biomarkers

  • N/A

Drug/Treatment

  • Tocilizumab

Outcome

  • N/A

Study Design

  • Randomized

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Roche/Genentech

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved